Tvardi Therapeutics, Inc.

TVRDNasdaq· Pharmaceutical Preparations

Price History

Revenue

$7.1M

▼ 66.0% YoY

Net Income

-$70.9M

▲ 40.2% YoY

EPS

$-15.53

▲ 40.9% YoY

Cash

$37.9M

▼ 26.8% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.